Found 4 results
Filters: Author is Krolewski, Andrzej S  [Clear All Filters]
2017
Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS.  2017.  Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.. Diabetes Care. 40(3):383-390.
2014
Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J et al..  2014.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.. Kidney Int. 85(5):1214-24.
2013
Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, E Weil J, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ et al..  2013.  From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.. Diabetes. 62(7):2605-12.
Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS.  2013.  Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.. PLoS One. 8(3):e57751.